skip to content
The new drug reimbursement game : a regulator's guide to playing and winning Preview this item
ClosePreview this item
Checking...

The new drug reimbursement game : a regulator's guide to playing and winning

Author: Brita Pekarsky
Publisher: Switzerland : Adis, [2014] ©2015
Edition/Format:   eBook : Document : EnglishView all editions and formats
Summary:
This comprehensive text presents a rigorous framework from within which regulators can respond strategically to the claim by the pharmaceutical industry that lower drug prices today lead to a loss for the population's future health due to less innovation. ℗ It starts with a critical review of the empirical evidence of the return to consumers on their ongoing investment into high drug prices in order to increase  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

 

Find a copy online

Links to this item

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Electronic books
Additional Physical Format: Print version:
Pekarsky, Brita A.K.
New Drug Reimbursement Game : A Regulator's Guide to Playing and Winning.
Cham : Springer International Publishing, ©2014
Material Type: Document, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: Brita Pekarsky
ISBN: 9783319089034 331908903X 3319089021 9783319089027
OCLC Number: 893117122
Description: 1 online resource : illustrations
Contents: Foreword; Acknowledgements; Abbreviations; Contents; Chapter 1: Introduction; 1.1 The Regulator℗þs Challenge; 1.2 Is It Plausible That the Threat Exists and That it Influences the Price of New Drugs?; 1.2.1 What Is a Threat?; 1.2.2 A Public Domain Expression of This Threat: The Australian-US FTA; 1.2.3 The Threat Exists and It Is Plausible That It Influences Decisions; 1.3 What Is the Evidence Upon Which This Threat Is Founded?; 1.4 What Are the Current Options for the Decision Threshold?; 1.4.1 Existing Options for the Decision Threshold. 1.4.2 The Health Shadow Price as the Decision Threshold1.5 The Framework for This Research; 1.5.1 Price-Effectiveness Analysis; 1.5.2 The Role of the Narrative in the Models and the Research; 1.6 Overview of Book: Concepts, Tools, Rules of the Game; 1.7 Outline of Book; 1.8 Playing and Winning the New Drug Reimbursement Game; References; Part I: The Political Economy of New Drugs and the Value of Pharmaceutical Innovation; Chapter 2: Reframing the Political Economy of New Drugs; 2.1 The Political Economy of New Drugs. 2.2 The Rate of Return on Investment in Pharmaceutical RandD and the Political Economy2.3 Is the Political Economy of New Drugs Constant?; 2.4 Reframing the Political Economy; 2.4.1 Architecture of Evidence Based Policy; 2.4.2 Prevailing Political Economy; 2.4.3 An Alternative Political Economy of New Drugs; 2.4.4 Comparison of Prevailing and Proposed Frames; 2.5 Conclusion; References; Chapter 3: The Social Rate of Return on Investment in Pharmaceutical Research and Development; 3.1 The Reimburser℗þs Problem; 3.2 A Closer Look at the Evidence Supporting Pharma℗þs Lobbying. 3.2.1 Why Is Return on Consumers℗þ Investment in Pharmaceutical RandD Important?3.2.2 What Is the Evidence of the Return on Consumers℗þ Investment?; 3.2.2.1 A Review of the Literature; 3.2.2.2 The Two Published Estimates of the Social Return to Consumers℗þ Investment in High Prices; 3.3 Fixed, Constrained and Unconstrained Budgets; 3.3.1 Four Types of Budgets; 3.3.2 Why Is It Useful to Have Four Classifications of Budgets?; 3.4 Accommodating the Budget Constraint in the Return on RandD; 3.4.1 A General Expression for the Rate of Return on Consumer Investment in Pharmaceutical RandD. 3.4.1.1 The Denominator Captures the Full Financial Value Investment3.4.1.2 The Financial Cost of Investment Is Translated into a Health Loss; 3.4.1.3 The Financial Cost to the Health Budget of Purchasing the New Drugs Is Included; 3.4.1.4 The Financial Costs of the New Drugs Are Converted to Health Effects; 3.5 Conditions Under Which More Future NMEs Means Less Future Health; 3.6 The Conventional Rate of Return and the Constrained Budget; 3.6.1 The Conditions Under Which Fewer Future NMEs and More Future Health Is Possible.
Responsibility: Brita A.K. Pekarsky.

Abstract:

This comprehensive text presents a rigorous framework from within which regulators can respond strategically to the claim by the pharmaceutical industry that lower drug prices today lead to a loss  Read more...

Reviews

Editorial reviews

Publisher Synopsis

"I like this book ... and would recommend it to anyonewho wishes to understand the negotiations between health-care payers andbiopharmaceutical companies. ... Pekarsky provides useful overviews of Read more...

 
User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/893117122> # The new drug reimbursement game : a regulator's guide to playing and winning
    a schema:MediaObject, schema:CreativeWork, schema:Book ;
    library:oclcnum "893117122" ;
    library:placeOfPublication <http://id.loc.gov/vocabulary/countries/sz> ;
    schema:about <http://experiment.worldcat.org/entity/work/data/2198148158#Topic/medical_care_marketing> ; # Medical care--Marketing
    schema:about <http://experiment.worldcat.org/entity/work/data/2198148158#Topic/political_science_public_policy_social_security> ; # POLITICAL SCIENCE--Public Policy--Social Security
    schema:about <http://dewey.info/class/362.1068/e23/> ;
    schema:about <http://experiment.worldcat.org/entity/work/data/2198148158#Topic/political_science_public_policy_social_services_&_welfare> ; # POLITICAL SCIENCE--Public Policy--Social Services & Welfare
    schema:author <http://experiment.worldcat.org/entity/work/data/2198148158#Person/pekarsky_brita> ; # Brita Pekarsky
    schema:bookFormat schema:EBook ;
    schema:copyrightYear "2015" ;
    schema:datePublished "2014" ;
    schema:description "Foreword; Acknowledgements; Abbreviations; Contents; Chapter 1: Introduction; 1.1 The Regulator℗þs Challenge; 1.2 Is It Plausible That the Threat Exists and That it Influences the Price of New Drugs?; 1.2.1 What Is a Threat?; 1.2.2 A Public Domain Expression of This Threat: The Australian-US FTA; 1.2.3 The Threat Exists and It Is Plausible That It Influences Decisions; 1.3 What Is the Evidence Upon Which This Threat Is Founded?; 1.4 What Are the Current Options for the Decision Threshold?; 1.4.1 Existing Options for the Decision Threshold."@en ;
    schema:description "This comprehensive text presents a rigorous framework from within which regulators can respond strategically to the claim by the pharmaceutical industry that lower drug prices today lead to a loss for the population's future health due to less innovation. ℗ It starts with a critical review of the empirical evidence of the return to consumers on their ongoing investment into high drug prices in order to increase future innovation.℗ The implicit, critical and unrealistic assumption inherent in these studies is identified, namely that the health budget can be expanded to purchase drugs at higher."@en ;
    schema:exampleOfWork <http://worldcat.org/entity/work/id/2198148158> ;
    schema:genre "Electronic books"@en ;
    schema:inLanguage "en" ;
    schema:isSimilarTo <http://worldcat.org/entity/work/data/2198148158#CreativeWork/new_drug_reimbursement_game_a_regulator_s_guide_to_playing_and_winning> ;
    schema:name "The new drug reimbursement game : a regulator's guide to playing and winning"@en ;
    schema:productID "893117122" ;
    schema:url <http://link.springer.com/10.1007/978-3-319-08903-4> ;
    schema:url <http://public.eblib.com/choice/publicfullrecord.aspx?p=1965313> ;
    schema:url <http://ebookcentral.proquest.com/lib/ucm/detail.action?docID=1965313> ;
    schema:url <http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=864755> ;
    schema:url <http://dx.doi.org/10.1007/978-3-319-08903-4> ;
    schema:url <http://link.springer.com/openurl?genre=book&isbn=978-3-319-08902-7> ;
    schema:url <http://site.ebrary.com/id/10953334> ;
    schema:workExample <http://dx.doi.org/10.1007/978-3-319-08903-4> ;
    schema:workExample <http://worldcat.org/isbn/9783319089034> ;
    schema:workExample <http://worldcat.org/isbn/9783319089027> ;
    wdrs:describedby <http://www.worldcat.org/title/-/oclc/893117122> ;
    .


Related Entities

<http://experiment.worldcat.org/entity/work/data/2198148158#Person/pekarsky_brita> # Brita Pekarsky
    a schema:Person ;
    schema:familyName "Pekarsky" ;
    schema:givenName "Brita" ;
    schema:name "Brita Pekarsky" ;
    .

<http://experiment.worldcat.org/entity/work/data/2198148158#Topic/medical_care_marketing> # Medical care--Marketing
    a schema:Intangible ;
    schema:name "Medical care--Marketing"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/2198148158#Topic/political_science_public_policy_social_security> # POLITICAL SCIENCE--Public Policy--Social Security
    a schema:Intangible ;
    schema:name "POLITICAL SCIENCE--Public Policy--Social Security"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/2198148158#Topic/political_science_public_policy_social_services_&_welfare> # POLITICAL SCIENCE--Public Policy--Social Services & Welfare
    a schema:Intangible ;
    schema:name "POLITICAL SCIENCE--Public Policy--Social Services & Welfare"@en ;
    .

<http://link.springer.com/openurl?genre=book&isbn=978-3-319-08902-7>
    rdfs:comment "Springer eBooks (Medicine 2015)" ;
    .

<http://worldcat.org/entity/work/data/2198148158#CreativeWork/new_drug_reimbursement_game_a_regulator_s_guide_to_playing_and_winning>
    a schema:CreativeWork ;
    rdfs:label "New Drug Reimbursement Game : A Regulator's Guide to Playing and Winning." ;
    schema:description "Print version:" ;
    schema:isSimilarTo <http://www.worldcat.org/oclc/893117122> ; # The new drug reimbursement game : a regulator's guide to playing and winning
    .

<http://worldcat.org/isbn/9783319089027>
    a schema:ProductModel ;
    schema:isbn "3319089021" ;
    schema:isbn "9783319089027" ;
    .

<http://worldcat.org/isbn/9783319089034>
    a schema:ProductModel ;
    schema:isbn "331908903X" ;
    schema:isbn "9783319089034" ;
    .

<http://www.worldcat.org/title/-/oclc/893117122>
    a genont:InformationResource, genont:ContentTypeGenericResource ;
    schema:about <http://www.worldcat.org/oclc/893117122> ; # The new drug reimbursement game : a regulator's guide to playing and winning
    schema:dateModified "2018-01-05" ;
    void:inDataset <http://purl.oclc.org/dataset/WorldCat> ;
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.